Kintor Pharmaceutical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Youzhi Tong
Chief executive officer
CN¥6.9m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.6yrs |
| CEO ownership | 10.7% |
| Management average tenure | no data |
| Board average tenure | 4.2yrs |
Recent management updates
Recent updates
Is Kintor Pharmaceutical (HKG:9939) Using Debt In A Risky Way?
Oct 07
Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?
Nov 16Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?
Apr 28Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?
Dec 06Is Kintor Pharmaceutical (HKG:9939) Using Debt Sensibly?
Sep 01Kintor Pharmaceutical Limited (HKG:9939) Insiders Increased Their Holdings
Feb 17CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥920m |
| Mar 31 2024 | n/a | n/a | -CN¥991m |
| Dec 31 2023 | CN¥7m | n/a | -CN¥1b |
| Sep 30 2023 | n/a | n/a | -CN¥854m |
| Jun 30 2023 | n/a | n/a | -CN¥648m |
| Mar 31 2023 | n/a | n/a | -CN¥801m |
| Dec 31 2022 | CN¥7m | CN¥6m | -CN¥954m |
| Sep 30 2022 | n/a | n/a | -CN¥995m |
| Jun 30 2022 | n/a | n/a | -CN¥1b |
| Mar 31 2022 | n/a | n/a | -CN¥938m |
| Dec 31 2021 | CN¥6m | CN¥4m | -CN¥842m |
| Sep 30 2021 | n/a | n/a | -CN¥740m |
| Jun 30 2021 | n/a | n/a | -CN¥639m |
| Mar 31 2021 | n/a | n/a | -CN¥573m |
| Dec 31 2020 | CN¥3m | CN¥2m | -CN¥508m |
| Sep 30 2020 | n/a | n/a | -CN¥419m |
| Jun 30 2020 | n/a | n/a | -CN¥330m |
| Mar 31 2020 | n/a | n/a | -CN¥281m |
| Dec 31 2019 | CN¥2m | CN¥2m | -CN¥233m |
Compensation vs Market: Youzhi's total compensation ($USD946.95K) is above average for companies of similar size in the Hong Kong market ($USD231.54K).
Compensation vs Earnings: Youzhi's compensation has been consistent with company performance over the past year.
CEO
Youzhi Tong (62 yo)
6.6yrs
Tenure
CN¥6,911,000
Compensation
Dr. Youzhi Tong serves as the Executive Chairman of the Board and Chief Executive Officer of Kintor Pharmaceutical Limited and has been its Executive Director since May 16, 2018. Dr. Tong is Founder of Kin...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 6.6yrs | CN¥6.91m | 10.74% HK$ 45.6m | |
| Chief Medical Officer & Executive Director | 1.7yrs | CN¥4.66m | no data | |
| Independent Non-Executive Director | 5.3yrs | CN¥272.00k | no data | |
| Non-Executive Director | 3.5yrs | no data | no data | |
| Independent Non-Executive Director | 5.3yrs | CN¥272.00k | no data | |
| Independent Non-Executive Director | 4.2yrs | CN¥272.00k | no data | |
| Non-Executive Director | 3.3yrs | no data | no data |
4.2yrs
Average Tenure
59yo
Average Age
Experienced Board: 9939's board of directors are considered experienced (4.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 06:26 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kintor Pharmaceutical Limited is covered by 8 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Peng Zou | China International Capital Corporation Limited |
| Bing Zhao | China Renaissance Securities |
| Blanco Zhou | China Renaissance Securities |